Adverse events66

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 66

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anemia	Blood and lymphatic system disorders	AG-348 in Participants With Sickle Cell Disease	3	17	3
other	Elevated C-Reactive Protein (CRP)	Blood and lymphatic system disorders	AG-348 in Participants With Sickle Cell Disease	1	17	1
other	Iron deficiency anemia	Blood and lymphatic system disorders	AG-348 in Participants With Sickle Cell Disease	1	17	1
other	Palpitations	Cardiac disorders	AG-348 in Participants With Sickle Cell Disease	1	17	1
other	Corneal scar	Eye disorders	AG-348 in Participants With Sickle Cell Disease	1	17	1
other	Red eye (bilateral)	Eye disorders	AG-348 in Participants With Sickle Cell Disease	1	17	2
other	Diarrhea	Gastrointestinal disorders	AG-348 in Participants With Sickle Cell Disease	2	17	2
other	Helicobacter Pylori	Gastrointestinal disorders	AG-348 in Participants With Sickle Cell Disease	2	17	2
other	Vomiting and diarrhea	Gastrointestinal disorders	AG-348 in Participants With Sickle Cell Disease	1	17	1
other	Gingival pain	Gastrointestinal disorders	AG-348 in Participants With Sickle Cell Disease	1	17	1
other	Chills	General disorders	AG-348 in Participants With Sickle Cell Disease	1	17	1
other	Edema limbs	General disorders	AG-348 in Participants With Sickle Cell Disease	1	17	1
other	Fatigue	General disorders	AG-348 in Participants With Sickle Cell Disease	1	17	3
other	Fever	General disorders	AG-348 in Participants With Sickle Cell Disease	1	17	1
other	Non-cardiac chest pain	General disorders	AG-348 in Participants With Sickle Cell Disease	1	17	1
other	Pain	General disorders	AG-348 in Participants With Sickle Cell Disease	4	17	4
other	Upper respiratory infection	Infections and infestations	AG-348 in Participants With Sickle Cell Disease	2	17	2
other	Fall	Injury, poisoning and procedural complications	AG-348 in Participants With Sickle Cell Disease	1	17	1
other	Finger laceration	Injury, poisoning and procedural complications	AG-348 in Participants With Sickle Cell Disease	1	17	1
other	Aspartate aminotransferase increased	Investigations	AG-348 in Participants With Sickle Cell Disease	3	17	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04000165/events

API reference For AI assistants

Adverse events66

Sources 3

Read this list from software.